• Investing Ideas
  • /
  • Chinese Pharmaceuticals & Biotech Strong Balance Sheet Stocks
267 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

600276

Jiangsu Hengrui Medicine
CN¥46.164.2%-6.3%CN¥293.5bCN¥57.27PE66.2xE19.6%0.4%

600535

Tasly Pharmaceutical Group
CN¥15.463.8%-2.6%CN¥23.0bCN¥13.97PE20.9xE11.9%2.1%

2550

Changzhou Qianhong BiopharmaLTD
CN¥5.347.4%-9.0%CN¥6.8bCN¥6.12PE37.6xE27.6%2.2%

300896

Imeik Technology DevelopmentLtd
CN¥214.802.6%-43.4%CN¥64.6bCN¥315.86PE32.8xE25.2%1.5%

2626

Xiamen Kingdomway Group
CN¥15.5510.6%-26.0%CN¥9.5bn/aPE36.4xn/a1.3%

301230

PharmaResources (Shanghai)
CN¥34.927.5%-17.5%CN¥3.8bn/aPE144.5xE76.8%1.0%

600080

Ginwa Enterprise (Group)
CN¥7.122.4%-6.6%CN¥2.7bn/aPS4.6xn/a0%

688046

GemPharmatech
CN¥12.725.1%-43.2%CN¥5.2bCN¥21.13PE32.8xE31.2%0.3%

301089

Tuoxin Pharmaceutical GroupLtd
CN¥33.503.2%-59.2%CN¥4.2bn/aPS10.8xn/a0.7%

300122

Chongqing Zhifei Biological Products
CN¥35.102.6%-33.7%CN¥84.0bCN¥62.47PE11.2xE22.8%2.3%

688073

Bide Pharmatech
CN¥35.118.6%-62.5%CN¥3.2bn/aPE32.3xE58.1%2.6%

603676

Tibet Weixinkang Medicine
CN¥9.147.8%-39.5%CN¥4.0bn/aPE16xn/a2.6%

2412

Hunan Hansen Pharmaceutical
CN¥5.7710.1%-16.4%CN¥2.9bn/aPE13.9xn/a5.2%

1367

Zhejiang Haisen Pharmaceutical
CN¥37.256.3%-36.5%CN¥2.5bn/aPE22.4xn/an/a

688315

Novogene
CN¥14.307.7%-58.4%CN¥5.9bCN¥21.48PE32.3xE19.6%0.3%

601089

Beijing Foyou PharmaLTD
CN¥15.742.9%-18.6%CN¥7.4bn/aPE14.6xn/a3.2%

688767

Hangzhou Biotest BiotechLtd
CN¥28.6413.7%-15.3%CN¥3.1bn/aPE22.7xn/a7.7%

504

Landfar Bio-medicine
CN¥7.8915.4%-34.1%CN¥2.6bn/aPS20.3xn/an/a

3020

Hefei Lifeon Pharmaceutical
CN¥23.639.7%-40.3%CN¥3.8bn/aPE19.8xE29.9%2.1%

301258

Suzhou Fushilai Pharmaceutical
CN¥28.1423.9%-32.3%CN¥2.6bn/aPE38.9xn/a2.1%

300181

Zhejiang Jolly PharmaceuticalLTD
CN¥14.912.5%10.4%CN¥10.5bn/aPE24.4xE22.3%3.0%

600422

KPC PharmaceuticalsInc
CN¥22.723.3%-2.2%CN¥17.2bCN¥25.01PE39.8xE27.7%0.9%

688373

Shanghai MicuRx Pharmaceutical
CN¥5.113.7%-47.3%CN¥3.3bCN¥8.55PS31.4xE-0.2%n/a

2349

Jinghua Pharmaceutical Group
CN¥7.882.2%-27.6%CN¥6.4bn/aPE27.8xn/a1.0%
Page 1 of 12
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.